In this issue:
Nivolumab for completely resected Merkel cell carcinoma
Survival after Mohs surgery for early-stage Merkel cell carcinoma
Cutaneous adverse events with immune checkpoint inhibitors
Major CV events with JAK inhibitors for AD
VTE risk in AD
Topical minoxidil vs. bimatoprost for eyebrow hypotrichosis
Adalimumab ± surgery for hidradenitis suppurativa
Fostamatinib for moderate-to-severe hidradenitis suppurativa
Autoimmune disorder risk after COVID-19 mRNA vaccines
Spesolimab for moderate-to-severe palmoplantar pustulosis
Please login below to download this issue (PDF)